Publikationen von F. Holsboer

Siegmund, A.; Dahlhoff, M.; Habersetzer, U.; Mederer, A.; Wolf, E.; Holsboer, F.; Wotjak, C. T.: Maternal inexperience as a risk factor of innate fear and PTSD-like symptoms in mice. Journal of Psychiatric Research 43 (14), S. 1156 - 1165 (2009)

Touma, C.; Knapman, A.; Heinzmann, J. M.; Fenzl, T.; Holsboer, F.; Landgraf, R.: Mice selected for extremes in stress reactivity: modeling clinically relevant endophenotypes of major depression. Pharmacopsychiatry 42 (5), S. 244 - 244 (2009)

Unschuld, P. G.; Ising, M.; Roeske, D.; Erhardt, A.; Specht, M.; Ripke, S.; Uhr, M.; Kloiber, S.; Müller-Myhsok, B.; Holsboer, F. et al.; Binder, E. B.: Polymorphisms in the gene encoding the neuropeptide galanin are associated with HPA-axis dysregulation and symptome severity in major-depressive- and anxiety-disorder patients. Pharmacopsychiatry 42 (5), S. 244 - 244 (2009)

Walser, S. M.; Henniger, M.; Oldekamp, J.; Holsboer, F.; Wurst, W.; Sillaber, I.; Deussing, J. M.: Functional validation of P2RX7 as a susceptibility marker for depression using humanized mouse mutants. Pharmacopsychiatry 42 (5), S. 246 - 246 (2009)

Wegerer, M.; Adena, S.; Binder, E. B.; Huber, J.; Sailer, U.; Bettecken, T.; Müller-Myhsok, B.; Modell, S.; Holsboer, F.; Ising, M.: Polymorphisms within the 4-aminobutyrate aminotransferase gene are associated with long-latency somatosensory potentials in families vulnerable for affective disorders. Pharmacopsychiatry 42 (5), S. 246 - 246 (2009)

Wolf, M.; Wang, X. D.; Scharf, S. H.; Liebl, C.; Holsboer, F.; Müller, M. B.; Schmidt, M. V.: Effects of acute and long-term chronic social stress and aging on cognition: involvement of novel synaptic cell adhesion molecules. Pharmacopsychiatry 42 (5), S. 248 - 248 (2009)

Wolff, G. v.; Avrabos, C.; Refojo, D.; Holsboer, F.; Deussing, J. M.; Eder, M.: High-speed voltage-sensitive dye imaging reveals an enhancing effect of corticotropin-releasing hormone (CRH) on neuronal activity propagation through the hippocampal formation. Pharmacopsychiatry 42 (5), S. 248 - 248 (2009)

Zimmermann, N.; Zschocke, J.; Bettecken, T.; Pütz, B.; Holsboer, F.; Rein, T.: Characterisation of DNA methylation marks in stress exposed hippocampal astrocytes. Pharmacopsychiatry 42 (5), S. 249 - 249 (2009)

Zimmermann, P.; Brückl, T.; Pfister, H.; Lieb, R.; Wittchen, H. U.; Holsboer, F.; Ising, M.; Binder, E. B.; Uhr, M.; Nocon, A.: The interplay of variations in the FKBP5 gene and adverse life events in predicting the first onset of depression during a ten-year follow-up. Pharmacopsychiatry 42 (5), S. 249 - 249 (2009)

Czisch, M.; Wehrle, R.; Stiegler, A.; Peters, H.; Andrade, K.; Holsboer, F.; Sämann, P. G.: Acoustic Oddball during NREM Sleep: A Combined EEG/fMRI Study. PLoS ONE 4 (8), doi: 10.1371/journal.pone.0006749 (2009)

Zimmermann, U. S.; Buchmann, A. F.; Spring, C.; Uhr, M.; Holsboer, F.; Wittchen, H. U.: Ethanol administration dampens the prolactin response to psychosocial stress exposure in sons of alcohol-dependent fathers. Psychoneuroendocrinology 34 (7), S. 996 - 1003 (2009)

Rupprecht, R.; Rammes, G.; Eser, D.; Baghai, T. C.; Schüle, C.; Nothdurfter, C.; Troxler, T.; Gentsch, C.; Kalkman, H. O.; Chaperon, F. et al.; Uzunov, V.; McAllister, K. H.; Bertaina-Anglade, V.; La Rochelle, C. D.; Tuerck, D.; Floesser, A.; Kiese, B.; Schumacher, M.; Landgraf, R.; Holsboer, F.; Kucher, K.: Translocator Protein (18 kD) as Target for Anxiolytics Without Benzodiazepine-Like Side Effects. Science 325 (5939), S. 490 - 493 (2009)

Inkster, B.; Nichols, T. E.; Saemann, P. G.; Auer, D. P.; Holsboer, F.; Muglia, P.; Matthews, P. M.: Association of GSK3 beta Polymorphisms With Brain Structural Changes in Major Depressive Disorder. Archives of General Psychiatry 66 (7), S. 721 - 728 (2009)

Heck, A.; Lieb, R.; Ellgas, A.; Pfister, H.; Lucae, S.; Roeske, D.; Pütz, B.; Müller-Myhsok, B.; Uhr, M.; Holsboer, F. et al.; Ising, M.: Investigation of 17 candidate genes for personality traits confirms effects of the HTR2A gene on novelty seeking. Genes Brain and Behavior 8 (4), S. 464 - 472 (2009)

Schmidt, M. V.; Sterlemann, V.; Wagner, K.; Niederleitner, B.; Ganea, K.; Liebl, C.; Deussing, J. M.; Berger, S.; Schutz, G.; Holsboer, F. et al.; Müller, M. B.: Postnatal Glucocorticoid Excess Due to Pituitary Glucocorticoid Receptor Deficiency: Differential Short- and Long-Term Consequences. Endocrinology 150 (6), S. 2709 - 2716 (2009)

Thoeringer, C. K.; Ripke, S.; Unschuld, P. G.; Lucae, S.; Ising, M.; Bettecken, T.; Uhr, M.; Keck, M. E.; Mueller-Myhsok, B.; Holsboer, F. et al.; Binder, E. B.; Erhardt, A.: The GABA transporter 1 (SLC6A1): a novel candidate gene for anxiety disorders. Journal of Neural Transmission 116 (6), S. 649 - 657 (2009)

Chechko, N.; Wehrle, R.; Erhardt, A.; Holsboer, F.; Czisch, M.; Sämann, P. G.: Unstable Prefrontal Response to Emotional Conflict and Activation of Lower Limbic Structures and Brainstem in Remitted Panic Disorder. PLoS ONE 4 (5), doi: 10.1371/journal.pone.0005537 (2009)

Laenger, A.; Lang-Rollin, I.; Kozany, C.; Zschocke, J.; Zimmermann, N.; Ruegg, J.; Holsboer, F.; Hausch, F.; Rein, T.: XAP2 inhibits glucocorticoid receptor activity in mammalian cells. FEBS Letters 583 (9), S. 1493 - 1498 (2009)

Liberman, A. C.; Druker, J.; Refojo, D.; Holsboer, F.; Arzt, E.: Glucocorticoids inhibit GATA-3 phosphorylation and activity in T cells. FASEB Journal 23 (5), S. 1558 - 1571 (2009)

Risbrough, V. B.; Geyer, M. A.; Hauger, R. L.; Coste, S.; Stenzel-Poore, M.; Wurst, W.; Holsboer, F.: CRF1 and CRF2 Receptors are Required for Potentiated Startle to Contextual but not Discrete Cues. Neuropsychopharmacology 34 (6), S. 1494 - 1503 (2009)